Transcatheter Self-expandable Valve Implantation for the Treatment of Severe Native Aortic Regurgitation

Recruiting now · Not applicable

Conditions studied: Aortic Valve Disease

In brief

Prospective, multicenter, randomized trial.

Key facts

Study ID
NCT04864145
Run by
Nanjing First Hospital, Nanjing Medical University
People needed
210
Starts
2021-05-21
Expected to finish
2031-05-30
Last updated by the study team
2026-04-08

Who can join

Age: 60 and older, up to 90. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.